We have now detected that you’re utilizing Web Explorer. For the most effective Barrons.com expertise, please replace to a current browser.
abstract
abstract
we
Europe
Asia
FX
charges
Futures
Alternate Traded Funds
encryption
![](https://www.barrons.com/asset/barrons/images/barrons-logo.png)
This model is for private, non-commercial use solely. To order presentation-ready copies to distribute to colleagues, shoppers or shoppers, go to http://www.djreprints.com.
https://www.barrons.com/articles/modern-earnings-stock-price-9128952e
-
Biotechnology and Prescribed drugs
-
Earnings preview
Up to date August 3, 2023 12:01 AM ET / Unique August 2, 2023 4:00 PM ET
-
Request a reprint
-
Print the article
Moderna’s earnings are coming. The demand for a Covid-19 vaccine can be our high precedence.
Moderna is about to report second-quarter earnings Thursday as the corporate stands getting ready to an unsure transition into the industrial Covid-19 vaccine market, with questions looming over how a lot demand stays for the vaccines three years after their launch.
There was an error. Please attempt once more.
Thanks
This text has been despatched to